Hôpital Privé Paul d'Egine
Champigny-sur-Marne, 94500, France
NCT Number: NCT05150353
This study is based on the hypothesis that MRI could make it possible to non-invasively detect these amyloid deposits at the level of the wrist using parametric sequences known as T1 mapping, in the form of an extension of T1 in the wrists. areas where amyloid deposits are found in the wrist.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Champigny-sur-Marne, 94500, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patient group:
Healthy volunteers:
Exclusion criteria
Patient group:
Healthy volunteer:
Wrist MRI
Time frame: 1 day
GCS Ramsay Santé pour l'Enseignement et la Recherche
Other
Detection of Amyloid Deposits in the Wrist by MRI With Mapping and High Resolution Sequences in Systemic Amyloidosis
Acronym: AMYLOCARP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03431896
AL Amyloidosis, Alzheimer Disease
Cleveland, Ohio, United States
View Trial DetailsNCT03923920
Alzheimer Disease, Amyloid
Cleveland, Ohio, United States
View Trial DetailsNCT04270175
AL Amyloidosis, Alzheimer Disease
Palo Alto, California, United States
View Trial DetailsNCT05138848
Alzheimer Disease, Alzheimer Disease, Late Onset
Pittsburgh, Pennsylvania, United States
View Trial Details